The obtained data suggested that RBCK1 was expressed at higher levels in a wide array of tumors relative to normal tissues, especially digestive system tumors such as CHOL, COAD, LIHC, READ, STAD, and PAAD. Here, RBCK1 is linked to digestive system neoplasm.